Aktis Oncology prices upsized US IPO at $18 per share
Group 1 - Aktis Oncology has priced its upsized U.S. initial public offering at $18 per share [1] - The IPO is expected to raise approximately $318 million [1]
Group 1 - Aktis Oncology has priced its upsized U.S. initial public offering at $18 per share [1] - The IPO is expected to raise approximately $318 million [1]